1 Mg Anastrozole Tablets IP

Name: 1 Mg Anastrozole Tablets IP
Brand: NEETCO BIOPHARMA
Price: 299 INR
Availability: InStock

Price 299 INR/ Strip

Get a Price/Quote

MOQ : 1 Strip

1 Mg Anastrozole Tablets IP Specification

Indication
Breast cancer in postmenopausal women

Dosage Form
Tablet

Salt Composition
Anastrozole 1 mg

Enzyme Types
Aromatase Inhibitor

Feature
Non-steroidal aromatase inhibitor for oral use

Ingredients
Anastrozole and excipients

Application
Oral administration for hormone receptor-positive breast cancer

Physical Color/Texture
White to off-white, round, film-coated tablet

Fermentation Smell
Odorless

Enzymatic Activity
Inhibits aromatase activity

Storage Instructions
Store below 30C, in a dry place, protected from light

Shelf Life
24-36 months (varies by manufacturer)

Route of Administration
Oral

Inactive Ingredients
Lactose, magnesium stearate, povidone, maize starch

Minimum Order Quantity
As per supplier

Prescription Status
Prescription only

Tablet Strength
1 mg

Packaging Size
1 x 10 tablets/box, blister strip

Trade Name
Anastrozole Tablets IP

Brand Name
As per manufacturer

Shape
Round

ATC Code
L02BG03

About 1 Mg Anastrozole Tablets IP

Capitalise on the new, rare opportunity to acquire 1 mg Anastrozole Tablets IP-an uncommon solution designed for world-class treatment of hormone receptor-positive breast cancer in postmenopausal women. These top-notch, round, film-coated tablets feature a non-steroidal aromatase inhibitor formulation, ensuring superior efficacy with an odorless experience. Manufactured to global pharmaceutical standards and distributed from India, each blister pack contains 110 tablets. The inactive ingredients, including lactose and povidone, contribute to a stable, high-grade therapeutic profile for prescription-based use.

Exceptional Features and Targeted Usage

Benefit from the extra features of Anastrozole Tablets IP, including world-class quality and precise oral administration for hormone receptor-positive breast cancer. These round, white to off-white tablets are applied exclusively via the oral route, providing effective treatment for postmenopausal women. As a top-notch, non-steroidal aromatase inhibitor, this product guarantees consistent enzyme inhibition at the target site, supporting professional therapy under prescription guidance.

Sample Availability and Order Advantages

Request a quotation for sample availability and enjoy our supportive sample policy before placing bulk orders. With streamlined order processing at the lowest price, distributors and exporters can capitalise on quick access from our FOB port in India. We facilitate hassle-free product trials to help you evaluate quality and efficacy, ensuring reliable supply for your pharmaceutical needs.

FAQ's of 1 Mg Anastrozole Tablets IP:

Q: How is 1 mg Anastrozole Tablets IP administered to patients?

A: The tablets are administered orally, making them suitable for easy and convenient usage in clinical or home settings as prescribed by a healthcare professional.

Q: What indication does Anastrozole Tablets IP address?

A: Anastrozole Tablets IP is indicated primarily for hormone receptor-positive breast cancer in postmenopausal women, aiding in the inhibition of aromatase activity.

Q: When should these tablets be stored and what are the instructions?

A: Store the tablets below 30C, in a dry place, and shielded from light to maintain potency, with a shelf life generally ranging from 24 to 36 months per manufacturer guidelines.

Q: Where can distributors and suppliers order this product from?

A: Distributors, exporters, and suppliers can place orders or request samples through authorised pharmaceutical channels operating in and from India.

Q: What process should be followed for sample requests and order placement?

A: Interested parties should request a quotation and adhere to the supplier's sample policy, followed by streamlined order processing to secure competitive pricing and efficient delivery.

Q: How does the use of Anastrozole benefit postmenopausal women with breast cancer?

A: This medication inhibits aromatase enzyme activity, resulting in decreased estrogen production, thereby slowing the growth of hormone-dependent breast cancer cells.

Tell us about your requirement